Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07251101
NA

Hemodynamic Effects of Remimazolam vs Propofol During Robot-assisted Gynecologic Surgery

Sponsor: Ilsan Cha hospital

View on ClinicalTrials.gov

Summary

This single-center study at CHA Ilsan Medical Center compares intraoperative hemodynamics between remimazolam- and propofol-based total intravenous anesthesia (TIVA) in patients undergoing robot-assisted gynecologic surgery requiring pneumoperitoneum and steep Trendelenburg positioning.

Official title: A Randomized, Parallel, Open-label With Blinded Assessment Study Comparing Hemodynamic Profiles Between Remimazolam- and Propofol-based Total Intravenous Anesthesia in Patients Undergoing Robot-assisted Gynecologic Surgery

Key Details

Gender

FEMALE

Age Range

Any - 65 Years

Study Type

INTERVENTIONAL

Enrollment

58

Start Date

2026-05-02

Completion Date

2027-12-30

Last Updated

2026-03-27

Healthy Volunteers

No

Interventions

DRUG

Remimazolam

Induction with remimazolam 6 mg·kg-¹·h-¹ with remifentanil Ce 4 ng·mL-¹ (Minto model); maintenance remimazolam 1-2 mg·kg-¹·h-¹, titrated (±0.2) to maintain PSI 25-50 and hemodynamic targets. Standard care otherwise per protocol.

DRUG

Propofol

Induction with propofol Ce 4 ng·mL-¹ with remifentanil Ce 4 ng·mL-¹; maintenance propofol Ce 2.5-3.5 ng·mL-¹, titrated (±0.2) to maintain PSI 25-50 and hemodynamic targets. Standard care otherwise per protocol.

Locations (2)

CHA Ilsan Medical Center

Goyang-si, Gyeonggi-do, South Korea

CHA Ilsan Medical Center

Goyang-si, South Korea